Hostname: page-component-745bb68f8f-f46jp Total loading time: 0 Render date: 2025-01-26T21:15:14.036Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence and Fluconazole Susceptibility of Candida Species Recovered From the Oropharynx of Healthcare Workers (HCWs) and Non-HCWs

Published online by Cambridge University Press:  02 January 2015

Joel D. Klein  and
S. Levin
Joel D. Klein*
Affiliation:
Department of Pediatrics, Jefferson Medical College, Philadelphia, Pennsylvania; and Nemours Children's Clinic-Wilmington, Alfred I. duPont Hospital for Children, Wilmington, Delaware Christiana Care Health Services (Infectious Disease Laboratory), Wilmington, Delaware
S. Levin
Affiliation:
Christiana Care Health Services (Infectious Disease Laboratory), Wilmington, Delaware
*
Nemours Children's Clinic-Wilmington, Alfred I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19899
Get access Rights & Permissions [Opens in a new window]

Abstract

We compared oropharyngeal cultures and fluconazole susceptibility for Candida in 100 healthcare workers (HCWs) and 100 non-HCWs. Isolates were identified using standard microbiological methods. Susceptibility was determined by Etest and microliter method. There was no significant difference in prevalence or species of oropharyngeal Candida between HCWs and non-HCWs. Fluconazole resistance was infrequent.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 4 , April 2004 , pp. 352 - 354
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002. Approved standard M27-A2.Google Scholar
2.Berrouane, Y, Herwaldt, LA, Pfaller, MA. Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol 1999;37:531–537.CrossRefGoogle ScholarPubMed
3.Safdar, A, Chaturvedi, V, Cross, E, et al.Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob Agents Chemother 2001;45:2129–2133.CrossRefGoogle Scholar
4.Fanello, S, Bouchara, JP, Jousset, N, et al.Nosocomial Candida albicans acquisition in a geriatric unit: epidemiology and evidence for person-to-person transmission. J Hasp Infect 2001;47:46–52.CrossRefGoogle Scholar
5.Hunter, PR, Harrison, GA, Fraser, CA. Cross-infection and diversity of Candida albicans strain carriage in patients and nursing staff on an intensive care unit. J Med Vet Mycol 1990;28:317–325.CrossRefGoogle Scholar
6.Pfaller, MA. Epidemiology of candidiasis. J Hosp Infect 1995;30(suppl):329–338.CrossRefGoogle ScholarPubMed
7.Bonassoli, LA, Svidzinski, TI. Influence of the hospital environment on yeast colonization in nursing students. Med Mycol 2002;40:311–313.CrossRefGoogle ScholarPubMed
8.Reef, SE, Lasker, BA, Butcher, DS, et al.Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol 1998;36:1255–1259.CrossRefGoogle Scholar
9.Mahayni, R, Vazquez, JA, Zervos, MJ. Nosocomial candidiasis: epidemiology and drug resistance. Infect Agents Dis 1995;4:248–253.Google ScholarPubMed
10.Trick, WE, Fridkin, K, Edwards, JR, et al.Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002;35:627–630.CrossRefGoogle ScholarPubMed